Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Wu (NPI 1952342305)

Field	Value
Entity Type	Individual
Organization	Christopher Wu
Address	8902 N Meridian St
City	Indianapolis
State	IN
ZIP	46260
Taxonomy	Rheumatology Physician
NPI Enumerated	June 9, 2006

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider’s Medicare business totals $1.3M in lifetime Medicare revenue, with the top three Medicare codes accounting for 74.0% of that total; the leading drivers are J0717 ($464K, 34.0%), J0129 ($361.3K, 26.5%), and J3262 ($183.2K, 13.4%). These three codes dominate the revenue mix, indicating concentration of billings in a small set of high-revenue drug administrations rather than broad-based procedure revenue.

The billing mix is consistent with a rheumatology practice that delivers in-office biologic drug administrations and infusion services: high-revenue J-codes (J0717, J0129, J3262, J1745, J0897) appear alongside infusion/chemotherapy administration codes (96401, 96413, 96415) and routine rheumatology monitoring labs. This combination of biologic injectables, infusion administration codes, and diagnostic panels suggests operations centered on office-administered biologic therapies with supporting lab monitoring and outpatient follow-up.

Payer mix is effectively single-payer Medicare: total Medicare revenue is $1.3M while there is no Medicaid billing on file, so the provider’s recorded public-payer activity is concentrated entirely in Medicare. This absence of Medicaid billing means analyses of age/acuity or low-income patient mix should account for the lack of Medicaid claims data for this NPI.

National competitive standing for the primary biologic drugs is modest to upper-quartile rather than dominant: J0717 ranks #111 of 848 providers (87th percentile; typical, unremarkable volume), J0129 ranks #439 of 1221 (64th percentile; typical, unremarkable volume), and J3262 ranks #337 of 618 (46th percentile; typical, unremarkable volume). In other words, the provider is not a national outlier or market leader for most biologic agents but does occupy an upper-range position for J0717 specifically.

The practice shows notably above-typical activity for office evaluation/management and drug administration support: 99214 ranks #15312 of 479517 providers (97th percentile; notably above typical national volume) and 96401 ranks #159 of 3868 providers (96th percentile; notably above typical national volume). These high percentiles for 99214 and 96401 indicate a comparatively heavy volume of mid-level established patient visits and subcutaneous/intramuscular drug administrations relative to peers, consistent with ongoing management of complex chronic conditions.

Claim-level detail points to unitized billing for biologics: J0717 has 116K claims with a $4 avg paid/claim and its descriptor is per 1 mg, which explains the very high claim count paired with a low per-claim payment; similarly J0129 (10.6K claims, $34 avg paid/claim) and J3262 (36.6K claims, $5 avg paid/claim) show high-claim, low-unit-value patterns. These volumes and average payments are consistent with per-milligram or per-unit drug billing rather than single-administration flat fees.

The provider also bills a range of rheumatology monitoring labs and basic office procedures, reinforcing a comprehensive outpatient management model: examples include 82306 (124 claims, $3.6K), 86140 (372 claims, $1.9K), 85652 (379 claims, $1.1K), 86200 (39 claims, $507) and 36415 (498 claims, $4K). The presence of CCP, CRP, ESR, vitamin D testing and frequent phlebotomy supports routine disease activity monitoring and treatment safety surveillance typical for rheumatology practices that administer biologic therapies.

The NPI was enumerated 2006-06-09 (~20 years ago), indicating long tenure on Medicare rolls; combined with a focused revenue profile heavily weighted to biologic J-codes and above-typical E/M and administration activity, this pattern is consistent with an established office-based infusion/injection rheumatology operation rather than a newly emergent practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

34 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	116,000	$1	$464K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	10,630	$30	$361.3K
J3262	Injection, tocilizumab, 1 mg	36,640	$10	$183.2K
J0897	Injection, denosumab, 1 mg	5,940	$20	$106.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	890	$90	$77.3K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,420	$30	$62.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	690	$50	$36.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	340	$100	$31.9K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	50	$100	$5.5K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	420	$10	$4.2K

Showing 1–10 of 34

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 34 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Christopher Wu — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

34 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	14	30	10,630	$30	$391.1K
J3262	10	10	46,210	$1	$263.4K
J0717	1	20	42,400	$1	$198.8K
J1745	15	20	3,990	$30	$119.4K
J0897	44	220	2,730	$20	$74.9K
96413	26	120	140	$90	$19.1K
99214	221	10,540	110	$80	$15.5K
82306	24	110	50	$30	$11.7K
80053	43	230	90	$10	$8.5K
96401	2	60	100	$50	$8K

Showing 1–10 of 34

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Wu, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Indiana University Health, Inc	IN	Home Infusion Therapy Pharmacy	$0	$178.1M
Indiana University Health Care Associates, Inc	IN	General Practice Physician	$0	$125.4M
Indiana University Health Inc	IN	General Acute Care Hospital	$0	$111.5M
Indiana University Health Inc	IN	Children's Hospital	$0	$75.6M
Indiana University Health Arnett Inc	IN	General Acute Care Hospital	$0	$26M
Indiana University Health West Hospital Inc	IN	General Acute Care Hospital	$0	$16M
Indiana University Health North Hospital Inc	IN	General Acute Care Hospital	$0	$6.9M
Indiana University Health, Inc	IN	Cardiovascular Disease Physician	$0	$4.5M
Douglas Smith	IN	Rheumatology Physician	$1.5M	$0
Tracy Brenner	PA	Rheumatology Physician	$1.2M	$0

Nearby Providers

Other providers in the same ZIP code as Christopher Wu, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
St. Vincent Hospital & Health Care Center, Inc.	IN	General Acute Care Hospital	$0	$58.9M
Cep America LLC	IN	Emergency Medicine Physician	$0	$28.6M
St Vincent Pediatric Subspecialties	IN	Pediatrics Physician	$0	$20.8M
St Vincent Physician Services Hospital And Health Care Center	IN	Family Medicine Physician	$0	$14M
Imaging Associates Of Indiana, PC	IN	Diagnostic Radiology Physician	$0	$9.7M
Rebecca Bolon	IN	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$9M
Shadeland Anesthesia & Pain Associates Inc.	IN	Interventional Pain Medicine Physician	$0	$7.1M
Singh Bullard Pediatric Dentistry, P.C.	IN	Pediatric Dentistry	$0	$7M
Alta Healthcare	IN	Home Health Agency	$0	$6.6M
Indiana Hemophilia & Thrombosis Center, Inc.	IN	Hematology & Oncology Physician	$0	$5.6M

Christopher Wu — Billing Profile & Reimbursement Data

Sign up for Christopher Wu — Billing Profile & Reimbursement Data policy alerts

Christopher Wu — Billing Profile & Reimbursement Data

Sign up for Christopher Wu — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References